1. Home
  2. GNLX vs HYPR Comparison

GNLX vs HYPR Comparison

Compare GNLX & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genelux Corporation

GNLX

Genelux Corporation

N/A

Current Price

$2.68

Market Cap

123.1M

Sector

Health Care

ML Signal

N/A

Logo Hyperfine Inc.

HYPR

Hyperfine Inc.

N/A

Current Price

$0.84

Market Cap

101.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GNLX
HYPR
Founded
2001
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
123.1M
101.3M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
GNLX
HYPR
Price
$2.68
$0.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$17.25
$1.59
AVG Volume (30 Days)
364.3K
542.2K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
9.47
23.21
EPS
N/A
N/A
Revenue
$8,000.00
$13,563,000.00
Revenue This Year
N/A
$50.75
Revenue Next Year
N/A
$29.71
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5.22
52 Week Low
$2.29
$0.83
52 Week High
$8.54
$2.22

Technical Indicators

Market Signals
Indicator
GNLX
HYPR
Relative Strength Index (RSI) 45.04 32.62
Support Level $2.33 N/A
Resistance Level $2.98 $1.19
Average True Range (ATR) 0.17 0.04
MACD 0.01 0.00
Stochastic Oscillator 29.27 7.84

Price Performance

Historical Comparison
GNLX
HYPR

About GNLX Genelux Corporation

Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.

About HYPR Hyperfine Inc.

Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales, which consist of sales from subscriptions of bundled devices, maintenance, and software. The company is in the health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. The Company operates in one business segment, which includes all activities related to production, supply, service, and commercialization of the Swoop system.

Share on Social Networks: